William G. Wierda, M.D., Ph.D.; The University of Texas MD Anderson Cancer Center; 5Live; #ASCO2021
5:42
Chronic Lymphocytic Leukemia
William G. Wierda, M.D., Ph.D.; The University of Texas MD Anderson Cancer Center; 5Live; #ASCO2021
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 2: Acalabrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, MD_Anthony Mato, MSCE
8:16
-
Module 1: Ibrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs_MD_Anthony Mato, MD, MSCE
9:28
-
Module 3_Treatment Strategies in the Relapsed Refractory Setting_Matthew Davids, MD, MMSc_Jeffrey Bubis, DO, FACOI, FACP_Divis Khaira, MD
11:17